XmAb27564
Xencor
['xencor', 'abion']
labn feed: xencor presents clinical results from phase 1a study of xmab 564 at the eular 2023 congress: pasadena, calif.--(business wire)--xencor, inc. (nasdaq:xncr), a clinical-stage biopharmaceutical ... #losangeles #biotech 
Los Angeles and Orange County #California #biotech news and events, for jobs follow @labnjobs #losangeles #orangecounty #lifescience